These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6791219)

  • 1. A dual role for GABA in quasi-morphine abstinence behavior induced by di-n-propylacetate involving both initiation and termination.
    Van der Laan JW; Bruinvels J
    Psychopharmacology (Berl); 1981; 74(2):143-8. PubMed ID: 6791219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Di-n-propylacetate-induced abstinence behaviour as a possible correlate of increased GABA-ergic activity in the rat.
    de Boer T; Bartels K; Metselaar HJ; Bruinvels J
    Psychopharmacology (Berl); 1980; 71(3):257-67. PubMed ID: 6779333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of branched-chain fatty acids on GABA-degradation and behavior: further evidence for a role of GABA in quasi-morphine abstinence behavior.
    van der Laan JW; Jacobs AW; Bruinvels J
    Pharmacol Biochem Behav; 1980 Dec; 13(6):843-9. PubMed ID: 6782587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quasi-morphine withdrawal behaviour: indication for a specific involvement of the GABA-ergic nerve terminal compartment.
    van der Laan JW
    Life Sci; 1983; 33 Suppl 1():389-92. PubMed ID: 6420629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
    Casu M; Gale K
    J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipropylacetate-induced quasi-morphine abstinence behaviour in the rat: involvement of amygdaloid and thalamic structures.
    van der Laan JW; Bruinvels J
    Brain Res; 1981 Dec; 229(1):133-46. PubMed ID: 6272932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The modification of the ethanol withdrawal syndrome in rats by di-n-propylacetate.
    Noble EP; Gillies R; Vigran R; Mandel P
    Psychopharmacologia; 1976 Mar; 46(2):127-31. PubMed ID: 781711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of GABA-induced abstinence behaviour in naive rats by morphine and bicuculline.
    de Boer T; Metselaar HJ; Bruinvels J
    Life Sci; 1977 Mar; 20(6):933-41. PubMed ID: 191711
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of inhibitors of GABA-transaminase on hole-board exploration and on temperature. Relation with effects on quasi-morphine abstinence behaviour induced by sodium dipropylacetate.
    van der Laan JW; Weick G; van Bleek G
    Biochem Pharmacol; 1985 Nov; 34(21):3789-94. PubMed ID: 3933514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the mechanism of action of valproid acid].
    Löscher W; Frey HH
    Arzneimittelforschung; 1977; 27(5):1081-2. PubMed ID: 328017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant and antiaggressive properties of di-n-propyl acetate after repeated treatment.
    Simler S; Ciesielski L; Klein M; Mandel P
    Neuropharmacology; 1982 Feb; 21(2):133-40. PubMed ID: 6801539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of GABAergic system on naloxone-induced jumping in morphine-dependent mice.
    Zarrindast MR; Mousa-Ahmadi E
    Eur J Pharmacol; 1999 Sep; 381(2-3):129-33. PubMed ID: 10554880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of di-n-propylacetate on the 'binding of GABA to synaptosome-enriched fraction of rat cerebral cortex.
    Kulig BM; Gonzalez-Portal C; Somoza E; Defeudis FV
    Psychopharmacology (Berl); 1977 Aug; 53(3):255-7. PubMed ID: 408853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipropylacetate-induced quasi-morphine abstinence behaviour in the rat: suppression by alpha 2-adrenoceptor stimulation.
    van der Laan JW; Weick G; Hillen FC
    Psychopharmacology (Berl); 1983; 81(3):267-71. PubMed ID: 6139840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of the GABA-ergic link in the development of the tranquilizing effect in cats].
    Kozlovskaia MM; Kharlamov AN; Raevskiĭ KS; Val'dman AV
    Biull Eksp Biol Med; 1981; 91(1):45-8. PubMed ID: 6111364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dual action of valproic acid upon morphine analgesia and morphine withdrawal.
    Tamayo L; Contreras E
    Pharmacology; 1983; 26(6):297-302. PubMed ID: 6410418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine acutely and persistently attenuates nonvesicular GABA release in rat nucleus accumbens.
    Schoffelmeer AN; Wardeh G; Vanderschuren LJ
    Synapse; 2001 Nov; 42(2):87-94. PubMed ID: 11574945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipropylacetate-induced shaking behaviour in the rat: a role of spinal alpha 2-adrenoceptors.
    Van der Laan JW; Dirksen R
    Eur J Pharmacol; 1988 Aug; 152(3):197-205. PubMed ID: 2905999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsant activity of di-n-propylacetate and brain monoamine metabolism in the rat.
    Abed WT
    Clin Exp Pharmacol Physiol; 1990 Jan; 17(1):11-6. PubMed ID: 1693553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine and GABA metabolism and the anticonvulsant action of di-n-propylacetate and ethanolamine-O-sulphate.
    Horton RW; Anlezark GM; Sawaya MC; Meldrum BS
    Eur J Pharmacol; 1977 Feb; 41(4):387-97. PubMed ID: 139317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.